Please assess the completion status of the following clinical trial:

Trial Title: Intraumbilical Vein Injection of Oxytocin in Routine Practice for Active Management of the Third Stage of Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* gestational age between 37 and 42 weeks~* singleton pregnancy~* live fetus~* cephalic presentation~* neonatal birth weight of 2500-4500 g~* parity between one and five~* maternal age \< 35 years~* vaginal birth~Exclusion Criteria:~* blood pressure ≥ 140/90mmHg~* placenta previa~* placental abruption~* a history of any bleeding during pregnancy~* a history of curettage~* cesarean section or any uterine scar~* a history of postpartum hemorrhage~* polyhydramnios~* signs or symptoms of maternal infection~* known uterine anomalies~* history of any drug use during labor~* abnormal placentation)~* coagulation defects~* instrumental deliveries~* hemoglobin concentration \< 8 g/dL~* history of anticoagulant drugs~* beta-mimetic medications during pregnancy~* prolongation of the first stage of labor \> 15 hours.

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Saline group (Type: EXPERIMENTAL): Only 30 mL of saline was injected directly in the umbilical vein after clamping. The injection was performed with a 30-mL syringe and an 18-gauge needle around 1 to 2 cm from the introitus. The solution was injected slowly over 1 minute and at the end of the injection, the solution was milked toward the cord insertion.

Based on this trial design, predict the completion outcome and termination type (if applicable).